Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.
Clinical trial NCT02043730 · COMPLETED
Trial details
- NCT number
- NCT02043730
- Sponsor
- Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-03-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.